Mitral Valve Disease

Mitral valve disease, also known as myxomatous mitral valve disease or degenerative mitral valve disease, is the most common acquired heart condition in dogs, affecting millions of dogs worldwide. This progressive condition occurs when the mitral valve, which separates the left atrium from the left ventricle in the heart, deteriorates and fails to close properly. Understanding mitral valve disease is essential for dog owners because early detection, appropriate monitoring, and timely treatment can significantly extend life expectancy and maintain quality of life for affected dogs.

Mitral valve disease predominantly affects small to medium-sized breeds, with Cavalier King Charles Spaniels being the most severely affected breed, sometimes developing disease at very young ages. Other commonly affected breeds include Dachshunds, Miniature and Toy Poodles, Chihuahuas, Yorkshire Terriers, Maltese, Cocker Spaniels, Miniature Schnauzers, and Shih Tzus. While large breed dogs can develop mitral valve disease, they are affected less frequently. The condition typically develops in middle-aged to older dogs, with prevalence increasing significantly after age ten.

The severity of mitral valve disease exists on a spectrum, from mild valve changes causing no symptoms to severe disease resulting in congestive heart failure. In early stages, dogs may have a heart murmur detectable on examination but show no outward signs of illness. As the disease progresses over months to years, the heart enlarges to compensate for the leaking valve, eventually leading to symptoms such as coughing, exercise intolerance, and difficulty breathing. The rate of progression varies considerably among individual dogs, with some remaining stable for years while others progress more rapidly.

The impact of mitral valve disease on a dog's life depends heavily on the disease stage and how well it is managed. Dogs in early stages can live completely normal lives with regular monitoring. Even dogs who progress to heart failure often respond well to medications, enjoying good quality of life for extended periods with appropriate treatment. For owners, understanding the disease and committing to monitoring and medication schedules helps ensure their dogs receive optimal care throughout the disease course.

This comprehensive guide provides dog owners with detailed information about mitral valve disease, including how it develops, what symptoms to watch for, how it is diagnosed and staged, treatment options at each stage, and what to expect as the disease progresses. Armed with this knowledge, you can partner effectively with your veterinary team to give your dog the best possible outcomes.

Mitral valve disease develops when the valve tissue undergoes progressive degeneration, becoming thickened, nodular, and eventually unable to form a tight seal when the heart contracts. This degeneration occurs due to changes in the extracellular matrix of the valve, causing the normally thin, smooth valve leaflets to become distorted and irregular. As the valve fails to close completely, blood regurgitates backward from the left ventricle into the left atrium with each heartbeat, creating the characteristic heart murmur and starting a cascade of compensatory changes in the heart.

Genetic factors play a substantial role in mitral valve disease, as evidenced by the strong breed predispositions observed clinically. Cavalier King Charles Spaniels carry genetic factors that predispose them to early-onset, rapidly progressive disease, with some dogs showing murmurs before age five and high percentages affected by age ten. Research has identified specific genes associated with valve disease in this breed and others. The hereditary nature of the condition has led to breeding recommendations in some countries to reduce disease prevalence in high-risk breeds.

Breed predisposition extends beyond Cavalier King Charles Spaniels to include numerous small breed dogs. Dachshunds, Miniature Poodles, Chihuahuas, Yorkshire Terriers, Maltese, Pomeranians, and Cocker Spaniels all face elevated risks compared to the general dog population. The reason small breeds are more commonly affected than large breeds is not entirely understood, though differences in valve structure, genetics, and perhaps mechanical forces on the valves may contribute. Interestingly, when large breed dogs do develop mitral valve disease, they sometimes progress to heart failure more quickly than small breeds.

Age represents the most significant risk factor for mitral valve disease in predisposed breeds. The degenerative changes in the valve tissue accumulate over time, making disease increasingly likely and increasingly severe with advancing age. By age thirteen to fifteen, the majority of small breed dogs have some degree of mitral valve degeneration, though not all progress to clinical significance. The age-related nature of the disease means that dogs diagnosed young face longer periods of living with progressive disease.

Male dogs appear to have moderately higher rates of mitral valve disease than females, and male dogs may progress to heart failure slightly more quickly, though the reasons for this sex difference are not fully understood. Hormonal factors, differences in heart size relative to body size, or genetic factors linked to sex chromosomes have all been proposed as potential explanations.

While no specific lifestyle factors have been proven to cause or prevent mitral valve disease, overall cardiovascular health may influence disease progression. Obesity places additional strain on the heart, potentially accelerating progression in dogs with existing valve disease. Dental disease with chronic bacterial burden has been theoretically linked to heart valve damage, though the relationship in dogs with degenerative valve disease is not as clear as in some human conditions. Maintaining healthy weight and good dental health remains reasonable general health advice for all dogs, including those with or at risk for mitral valve disease.

The earliest sign of mitral valve disease is typically a heart murmur detected by your veterinarian during routine physical examination, often years before any symptoms develop. This murmur is caused by blood flowing backward through the leaky valve and can be heard with a stethoscope. The murmur's intensity generally correlates with disease severity, though this relationship is imperfect. Many owners are surprised when their seemingly healthy dog is found to have a heart murmur, as dogs in early disease stages show no outward signs of illness.

As mitral valve disease progresses, dogs develop compensatory changes that initially maintain normal function. The heart enlarges to accommodate the extra blood volume, and dogs may remain asymptomatic for extended periods despite significant heart changes. However, owners may notice subtle early warning signs including slightly decreased exercise tolerance, tiring more easily on walks, or mild reluctance to engage in vigorous play. These changes often develop so gradually that owners attribute them to normal aging rather than recognizing them as early disease signs.

Coughing represents one of the most common symptoms owners notice as mitral valve disease progresses. This cough results from enlargement of the left atrium pressing on the airways, and from fluid accumulation in or around the lungs. The cough is often described as dry and hacking, sometimes ending with a gagging or retching sound. It typically worsens at night or after rest, when the dog lies down and fluid redistributes in the chest. The cough may also increase with excitement or exertion. Any new or persistent cough in a dog known to have a heart murmur should prompt veterinary evaluation.

More advanced symptoms indicate progression toward or into congestive heart failure. Dogs may show labored or rapid breathing, breathe with increased effort, or seem unable to settle comfortably. Exercise intolerance becomes more pronounced, with dogs stopping during walks, refusing stairs, or showing reluctance to move. Some dogs experience fainting episodes, particularly with exertion or excitement, due to inadequate blood flow to the brain. Weight loss and decreased appetite often accompany advanced disease, and some dogs develop fluid accumulation in the abdomen, causing a pot-bellied appearance.

Emergency symptoms requiring immediate veterinary attention include severe difficulty breathing, extreme respiratory distress with open-mouth breathing, blue or purple-tinged gums indicating inadequate oxygenation, collapse, or sudden inability to stand. These signs suggest severe heart failure or related complications requiring immediate intervention. Dogs can deteriorate rapidly when congestive heart failure develops, making recognition of emergency symptoms potentially lifesaving.

Veterinary examination for mitral valve disease begins with careful auscultation, listening to the heart with a stethoscope. Your veterinarian will characterize the murmur's intensity, timing, and location, providing initial clues about severity. Physical examination also assesses heart rate and rhythm, breathing rate and effort, mucous membrane color, and any evidence of fluid accumulation. A complete history of symptoms, exercise tolerance, and any changes you have noticed helps guide the diagnostic approach.

Echocardiography, or cardiac ultrasound, represents the gold standard for diagnosing and staging mitral valve disease. This non-invasive imaging study allows direct visualization of the mitral valve, measurement of heart chamber sizes, assessment of heart muscle function, and evaluation of blood flow patterns. Specific measurements from echocardiography determine disease stage and guide treatment decisions. The ACVIM staging system classifies dogs from Stage A through Stage D based on echocardiographic findings and clinical status. Regular echocardiographic monitoring helps track disease progression and optimize treatment timing.

Additional diagnostic tests provide complementary information. Chest radiographs assess heart size, detect pulmonary edema indicating heart failure, and evaluate the airways. Electrocardiography records the heart's electrical activity and can identify arrhythmias that may accompany advanced disease. Blood pressure measurement may be included, as some medications used to treat heart disease affect blood pressure. Blood work including kidney values is important before starting certain medications and for ongoing monitoring.

Treatment recommendations depend on disease stage. Dogs in early stages without heart enlargement typically require monitoring only, with echocardiograms repeated periodically to track progression. Recent research has demonstrated that pimobendan, a medication that strengthens heart contractions and dilates blood vessels, significantly delays progression to heart failure in dogs with heart enlargement but no symptoms. This represents an important advancement in treatment, as previously dogs were only treated after developing symptoms.

Dogs in congestive heart failure require more aggressive treatment, typically combining multiple medications. Furosemide, a diuretic, removes excess fluid from the body and helps resolve pulmonary edema. Pimobendan continues as a cornerstone of treatment. ACE inhibitors such as enalapril or benazepril help reduce the heart's workload. Additional medications may be added based on individual response and disease characteristics. Spironolactone, another diuretic with beneficial cardiac effects, is sometimes included. Dogs with arrhythmias may need antiarrhythmic medications.

Surgical repair of the mitral valve is available at specialized centers and offers the possibility of cure rather than just management. However, this complex open-heart surgery requires highly specialized expertise, cardiopulmonary bypass, and significant financial resources. Outcomes have improved dramatically at experienced centers, with many dogs returning to normal cardiac function after successful surgery. Not all dogs are candidates for surgery, and availability remains limited. Costs for medical management vary based on medications used and monitoring frequency, ranging from modest monthly expenses to more significant costs for dogs requiring multiple medications and frequent veterinary visits.

While mitral valve disease cannot be completely prevented due to its genetic components, responsible breeding practices can help reduce disease prevalence in susceptible breeds. Screening breeding dogs with cardiac examination and echocardiography before breeding helps identify affected individuals. Some breed clubs have established cardiac screening protocols and registration programs. Selecting breeding stock from lines with lower disease prevalence and later onset may gradually improve breed health over generations.

For individual dogs, early detection through regular veterinary examinations represents the most effective strategy for optimal outcomes. Annual or semi-annual wellness examinations allow your veterinarian to detect heart murmurs when they first develop and track any changes over time. Dogs from high-risk breeds may benefit from earlier and more frequent cardiac screening. When a murmur is detected, echocardiography provides detailed staging information that guides monitoring and treatment decisions.

Ongoing monitoring for dogs diagnosed with mitral valve disease follows their disease stage. Dogs in early stages without heart enlargement may be rechecked annually with periodic echocardiography to watch for progression. Dogs with heart enlargement but no symptoms typically receive more frequent monitoring, perhaps every six months, to detect the optimal timing for starting medication. Dogs on treatment require regular rechecks to assess response, adjust medications, and monitor for side effects or progression.

Long-term management of dogs with mitral valve disease focuses on maintaining quality of life while optimizing cardiac function. Medication compliance is essential, and developing consistent routines helps ensure doses are not missed. Diet modifications may be recommended, including sodium restriction for dogs in heart failure and careful attention to maintaining healthy body weight. Moderate exercise is generally encouraged, though strenuous activity may need to be limited based on disease severity. Your veterinary team will provide individualized recommendations based on your dog's specific situation.

Support resources for owners of dogs with heart disease include veterinary cardiologists who can provide specialized expertise for complex cases or dogs who are not responding well to standard treatment. Many general practitioners collaborate with cardiologists while providing ongoing primary care. Online communities connect owners managing canine heart disease, sharing experiences and support. Understanding that many dogs with mitral valve disease live comfortable lives for years with appropriate management provides reassurance during what can initially feel like a frightening diagnosis.

Seek immediate emergency veterinary care if your dog with known heart disease shows severe breathing difficulty, including rapid open-mouth breathing, extreme respiratory effort, extending the neck to breathe, or blue-tinged gums. Collapse, fainting, or inability to stand requires emergency evaluation. Sudden severe worsening of symptoms, even if your dog seemed stable on current medications, may indicate acute heart failure decompensation needing immediate intervention. Dogs in severe respiratory distress can deteriorate quickly, making prompt emergency care essential.

Schedule a same-day or urgent appointment if you notice new or significantly worsened coughing, moderately increased breathing rate or effort, decreased appetite or unusual lethargy, inability to exercise or reluctance to move, or any new symptoms concerning you. Dogs who seem uncomfortable or restless, unable to settle or sleep normally, should be evaluated promptly. Changes in response to medications, such as decreased effectiveness of previously helpful treatments, warrant veterinary assessment. Any concerning changes in a dog with heart disease deserve timely attention.

Routine veterinary appointments should be maintained according to your veterinarian's recommended schedule based on your dog's disease stage. Keep scheduled recheck appointments even when your dog seems to be doing well, as monitoring allows early detection of disease progression. Report any subtle changes you observe between appointments, as owners often notice early signs before they become obvious. Annual or more frequent wellness examinations remain important even when heart disease is being managed, as these dogs need attention to their overall health.

Trust your observations of your dog's daily patterns. You are best positioned to notice subtle changes in breathing, coughing frequency, energy levels, or comfort that might indicate disease progression. If something seems different or concerning about how your dog is doing, contacting your veterinary team is always appropriate. Dogs with heart disease can change status relatively quickly, and early intervention when changes occur often produces better outcomes than waiting. Your partnership with your veterinary team in monitoring your dog is essential for providing the best possible care throughout the course of this common but manageable condition.